Improving healthcare services often begins with a decision made far from the bedside: what an organisation buys, from whom, and why. Effective procurement can secure safer medical devices, reliable medicines, responsive digital systems, and practical support for clinical teams. It can also reduce waste without turning patient care into a cost-cutting exercise. That balance is difficult.
Healthcare improvement pioneer Dr. Paul Batalden is widely associated with the observation, “Every system is perfectly designed to get the results it gets.” His insight applies directly to procurement. A hospital may purchase advanced equipment, yet patients can still face delays when training, maintenance, or workflow design receives little attention. Better healthcare service improvement therefore requires more than competitive prices. It requires evidence, clinician involvement, supplier accountability, and feedback from patients.
A strong procurement strategy connects purchasing choices with measurable service outcomes. These may include shorter waiting times, fewer equipment failures, improved infection control, and clearer communication. Procurement teams should examine total cost, not only the invoice. A cheaper infusion pump may become expensive when repairs are slow or spare parts disappear. Small details matter.
Still, procurement is not a cure-all. Poor staffing and fragmented leadership can undermine excellent contracts. Metrics may also overlook anxiety in a waiting room. That weakness deserves honest reflection. This article explores practical ways to align procurement with clinical experience, operational evidence, and patient needs. It considers transparent evaluation, ethical supplier partnerships, sustainable purchasing, and continuous review. The aim is not perfection. It is a more dependable system that learns before avoidable problems become routine.
WHO estimates that 20–40% of health spending may be lost through inefficiency and waste. Procurement is a major part of this problem. The waste is rarely dramatic. It often appears as expired supplies, duplicate orders, weak specifications, or urgent purchases at higher prices. An unopened box can represent both unused money and delayed care.
Procurement teams should map each purchase from request to delivery. Compare ordered quantities with actual patient demand. Review stock records every month. Check expiry dates before placing new orders. Require clear specifications and documented supplier comparisons. Simple digital alerts can flag unusual price changes or slow-moving inventory. These steps create evidence for better decisions, not just lower prices.
The WHO estimate is a warning, not a universal audit result. Local losses may be higher or lower. Some savings reports also look better on paper than in practice. A cheaper item can create repair costs, shortages, or clinical risks. Procurement leaders should therefore measure total value, including quality, delivery reliability, storage, and patient impact. They need to question familiar routines. A rushed approval may feel efficient today, yet leave shelves crowded with unsuitable stock tomorrow. Independent reviews can expose these blind spots, although they require time and honest records.
How to Improve Healthcare Services With Better Procurement?
Prioritize Medicines: They Consume 20–60% of Spending in Many Countries
Medicines can consume 20–60% of health spending in many countries. This makes pharmaceutical procurement a practical starting point for service improvement. A well-designed purchasing system protects budgets and keeps essential treatments available. Procurement teams should compare demand forecasts with clinic-level consumption data. A sudden increase in antibiotics may reflect an outbreak, poor prescribing, or inaccurate records. The numbers need context.
Effective procurement includes transparent tenders, quality checks, and reliable delivery schedules. Contracts should measure delivery times, product quality, and stockout frequency. Smaller, regular orders may reduce expiry losses in facilities with limited storage. However, low prices alone can create shortages when suppliers cannot deliver consistently. No procurement plan is perfect. A spreadsheet cannot explain every delay.
Tips: Build a list of essential medicines and update it regularly. Use minimum and maximum stock levels for each facility. Review expired products every month, not once a year. Invite pharmacists and clinicians to assess quality, packaging, and usability. Keep an audit trail for forecasts, supplier decisions, and emergency purchases. Test the process with one district before expanding it nationwide. Mistakes will appear. That is useful, if teams examine them honestly.
Medicines can represent approximately 20–60% of total health spending in many low- and middle-income countries. This wide range highlights the value of demand forecasting, pooled procurement, transparent pricing, and reliable inventory management.
Reference range: World Health Organization reporting on medicine expenditure in many developing countries. The midpoint is shown for orientation and is not a country-specific estimate.
How to Improve Healthcare Services With Better Procurement?
One in ten patients experiences harm during healthcare, according to the World Health Organization’s Global Patient Safety Action Plan 2021–2030. More than half of this harm is considered preventable. Procurement decisions can reduce that risk before products reach a clinic, ward, or operating room.
Quality controls should cover suppliers, materials, packaging, storage, and delivery records. Require documented specifications, independent testing, and traceable batch numbers. A low purchase price means little if a faulty device delays treatment. The OECD’s Economics of Patient Safety report estimates that safety failures may consume up to 15% of hospital expenditure in member countries. That cost includes rework, longer stays, and avoidable care. Small errors compound. Procurement teams should review near misses, not only confirmed failures. No checklist is perfect, and overconfidence can weaken controls.
Tips: Set acceptance criteria before purchasing. Audit high-risk suppliers regularly. Use barcode or batch tracking where practical. Ask clinical staff to test usability before contracts are renewed. Keep a clear escalation route for damaged, mislabeled, or inconsistent supplies. Review complaints monthly and connect them to purchasing data. Quality assurance needs evidence, not assumptions.
| Quality-Control Area | Evidence-Based Indicator | Reported Global Figure | Procurement Quality Control | Primary Source |
|---|---|---|---|---|
| Patient-safety risk screening | Patients experiencing harm during healthcare delivery | Approximately 1 in 10 patients | Include a documented patient-safety risk assessment in every major purchase, tender, and contract renewal. | World Health Organization (WHO), Patient Safety |
| Preventable-harm controls | Share of healthcare-related harm that is preventable | More than 50% | Use supplier qualification, product validation, staff training, traceability, and corrective-action requirements before award. | WHO, Patient Safety |
| Medication-safety procurement | Preventable medication-related harm | Medication-related harm accounts for a substantial proportion of preventable harm; WHO estimates related costs at approximately US$42 billion annually | Require clear labeling, standardized packaging, look-alike/sound-alike risk review, batch traceability, and recall procedures. | WHO, Medication Without Harm |
| Healthcare-associated infection prevention | Patients acquiring at least one healthcare-associated infection in acute-care hospitals | About 7% in high-income countries and 15% in low- and middle-income countries at any given time | Verify sterilization, disinfection, packaging integrity, storage conditions, expiry controls, and delivery cleanliness. | WHO, Global Report on Infection Prevention and Control |
| Primary and ambulatory-care safety | Patients harmed in primary and ambulatory care settings | Up to 4 in 10 patients; up to 80% of the harm may be preventable | Apply the same quality standards to outpatient supplies, diagnostic devices, referral materials, and home-use products. | WHO, Patient Safety |
| Product conformity and traceability | Ability to identify products, batches, distribution records, and recalls | No single universal global rate; WHO identifies traceability and surveillance as core patient-safety requirements | Maintain batch or serial-number records, certificates of conformity, inspection records, and documented recall tests. | WHO, Medical Devices and Patient Safety guidance |
| Incident reporting and supplier improvement | Use of adverse-event data to reduce recurring procurement-related risks | WHO recommends reporting, learning, and systems-based action; a universal global reporting rate is not established | Add mandatory incident notification, root-cause analysis, response timelines, and contract remedies to purchasing agreements. | WHO, Global Patient Safety Action Plan 2021–2030 |
| Equitable access to safe products | Availability of safe, effective, quality-assured healthcare products | WHO identifies access to safe and quality-assured care as a global patient-safety priority | Evaluate total cost of ownership, continuity of supply, storage requirements, accessibility, and quality—not purchase price alone. | WHO, Global Patient Safety Action Plan 2021–2030 |
Healthcare procurement improves when sourcing decisions are visible, measurable, and connected to patient care. In practice, a digital workflow replaces scattered emails, paper approvals, and delayed spreadsheet updates. Teams can compare approved suppliers, contract prices, order quantities, and delivery dates in one controlled record. This creates an audit trail without slowing urgent, clinically justified purchases. Small details matter.
Procurement leaders should track three operational KPIs:
For example, a surgical unit may discover that low-cost gloves create frequent rush orders. Those emergency purchases can erase the original savings.
Reliable reporting depends on clean item names, consistent units, and disciplined data entry. Access controls and regular reviews also protect sensitive purchasing information. Yet dashboards do not fix weak processes. If staff record receipts late, the lead-time metric becomes misleading. If demand changes suddenly, a higher stock level may be reasonable, not wasteful. Teams should investigate exceptions with clinicians, finance staff, and warehouse personnel before changing suppliers. That human review is sometimes slow. The dashboard is useful, but not neutral.
Reliable healthcare begins with reliable procurement. Hospitals should avoid depending on one supplier for essential medicines, diagnostic products, or protective equipment. A second qualified supplier can reduce shortages when transport fails, demand rises, or production slows. However, more suppliers do not automatically mean better resilience. Each supplier needs careful evaluation, documented controls, and regular performance reviews.
Procurement teams should align purchasing criteria with WHO quality standards and relevant national requirements. They can examine manufacturing practices, product specifications, batch records, storage conditions, and testing evidence. For temperature-sensitive products, teams should review cold-chain records from dispatch to delivery. Site audits also reveal practical weaknesses that paperwork may miss. A clean warehouse matters. So does accurate stock rotation. Quality checks should continue after delivery, not stop at contract signing.
Tips: Create a supplier scorecard covering quality, delivery reliability, capacity, traceability, and response time. Keep approved alternatives for critical items. Test emergency ordering procedures before a crisis occurs. In practice, smaller facilities may lack auditors or technical staff, so shared assessments can help. No plan is perfect. Teams should record failed deliveries, investigate causes, and adjust purchasing rules. Price alone can look attractive, yet a low-cost product becomes expensive when it causes delays, waste, or treatment interruptions. Candor improves decisions.